Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Methamphetamine | 6 | 2021 | 21 | 2.320 |
Why?
|
| Pro-Opiomelanocortin | 3 | 2023 | 14 | 1.870 |
Why?
|
| Ethanol | 11 | 2019 | 124 | 1.710 |
Why?
|
| Nucleus Accumbens | 2 | 2023 | 8 | 1.570 |
Why?
|
| Behavior, Animal | 6 | 2018 | 108 | 1.340 |
Why?
|
| Ventral Tegmental Area | 5 | 2024 | 10 | 1.330 |
Why?
|
| Dopaminergic Neurons | 6 | 2024 | 18 | 1.180 |
Why?
|
| Self Administration | 10 | 2025 | 23 | 1.100 |
Why?
|
| Motor Activity | 6 | 2018 | 148 | 1.080 |
Why?
|
| Corticotropin-Releasing Hormone | 5 | 2021 | 28 | 0.940 |
Why?
|
| Piperidines | 2 | 2025 | 48 | 0.920 |
Why?
|
| Fentanyl | 1 | 2025 | 35 | 0.900 |
Why?
|
| Cocaine | 3 | 2021 | 22 | 0.890 |
Why?
|
| Mice | 20 | 2025 | 4735 | 0.870 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 117 | 0.840 |
Why?
|
| Animals | 31 | 2025 | 10583 | 0.810 |
Why?
|
| alpha-MSH | 1 | 2022 | 7 | 0.780 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2022 | 5 | 0.780 |
Why?
|
| Hypoxia | 2 | 2013 | 90 | 0.770 |
Why?
|
| Peptides, Cyclic | 1 | 2022 | 30 | 0.760 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2021 | 4 | 0.740 |
Why?
|
| Alcohol Drinking | 8 | 2011 | 175 | 0.730 |
Why?
|
| Neurotensin | 2 | 2018 | 4 | 0.690 |
Why?
|
| Conditioning, Operant | 4 | 2025 | 11 | 0.640 |
Why?
|
| Aging | 3 | 2025 | 979 | 0.640 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 3 | 2014 | 10 | 0.630 |
Why?
|
| Sympathetic Nervous System | 3 | 2014 | 68 | 0.610 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 2 | 2016 | 2 | 0.580 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 1602 | 0.570 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 4 | 2014 | 12 | 0.510 |
Why?
|
| Male | 24 | 2025 | 13772 | 0.500 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2025 | 611 | 0.490 |
Why?
|
| Reinforcement Schedule | 3 | 2014 | 3 | 0.480 |
Why?
|
| Behavior, Addictive | 3 | 2014 | 23 | 0.460 |
Why?
|
| Food Deprivation | 2 | 2013 | 11 | 0.460 |
Why?
|
| Mesencephalon | 1 | 2014 | 6 | 0.450 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 187 | 0.440 |
Why?
|
| Electrophysiology | 1 | 2014 | 150 | 0.440 |
Why?
|
| Arterial Pressure | 1 | 2013 | 9 | 0.410 |
Why?
|
| Central Nervous System Stimulants | 3 | 2019 | 32 | 0.400 |
Why?
|
| Mice, Inbred DBA | 5 | 2018 | 30 | 0.400 |
Why?
|
| Exercise Tolerance | 1 | 2013 | 82 | 0.380 |
Why?
|
| Blood Pressure | 1 | 2013 | 355 | 0.380 |
Why?
|
| Neurons | 1 | 2013 | 291 | 0.350 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 1494 | 0.350 |
Why?
|
| Dopamine | 4 | 2019 | 22 | 0.350 |
Why?
|
| Mice, Transgenic | 5 | 2024 | 509 | 0.340 |
Why?
|
| Cues | 2 | 2025 | 40 | 0.340 |
Why?
|
| Sucrose | 5 | 2003 | 27 | 0.330 |
Why?
|
| Astrocytes | 2 | 2021 | 79 | 0.330 |
Why?
|
| Hypertension | 1 | 2013 | 309 | 0.330 |
Why?
|
| Feeding Behavior | 1 | 2011 | 103 | 0.330 |
Why?
|
| Rats | 10 | 2014 | 1587 | 0.320 |
Why?
|
| Urocortins | 1 | 2009 | 2 | 0.310 |
Why?
|
| Drinking Behavior | 1 | 2009 | 6 | 0.310 |
Why?
|
| Receptors, Neurotensin | 2 | 2018 | 2 | 0.280 |
Why?
|
| Genes, fos | 1 | 2005 | 13 | 0.240 |
Why?
|
| Ataxia | 1 | 2005 | 8 | 0.240 |
Why?
|
| GABA-A Receptor Agonists | 3 | 2014 | 4 | 0.240 |
Why?
|
| Alcoholic Intoxication | 1 | 2005 | 6 | 0.240 |
Why?
|
| Administration, Intravenous | 1 | 2025 | 30 | 0.230 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2024 | 7 | 0.220 |
Why?
|
| Casein Kinase II | 1 | 2024 | 17 | 0.220 |
Why?
|
| Central Nervous System Depressants | 2 | 2019 | 13 | 0.210 |
Why?
|
| beta-Endorphin | 1 | 2023 | 5 | 0.200 |
Why?
|
| Melanocortins | 1 | 2022 | 1 | 0.200 |
Why?
|
| Consummatory Behavior | 2 | 2001 | 2 | 0.190 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 223 | 0.190 |
Why?
|
| Nicotine | 1 | 2002 | 86 | 0.180 |
Why?
|
| Heart Rate | 2 | 2013 | 380 | 0.180 |
Why?
|
| Naloxone | 1 | 2001 | 19 | 0.180 |
Why?
|
| Narcotic Antagonists | 1 | 2001 | 32 | 0.180 |
Why?
|
| Rats, Long-Evans | 6 | 2003 | 35 | 0.170 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2019 | 7 | 0.170 |
Why?
|
| Microglia | 1 | 2020 | 68 | 0.160 |
Why?
|
| Locomotion | 1 | 2019 | 24 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 148 | 0.150 |
Why?
|
| Transcriptome | 1 | 2020 | 214 | 0.150 |
Why?
|
| Substantia Nigra | 2 | 2018 | 5 | 0.150 |
Why?
|
| Quality of Life | 1 | 2023 | 504 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2018 | 47 | 0.140 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 76 | 0.140 |
Why?
|
| Body Weight | 2 | 2013 | 250 | 0.140 |
Why?
|
| Muscimol | 2 | 2014 | 8 | 0.130 |
Why?
|
| Obesity | 1 | 2022 | 675 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2011 | 862 | 0.130 |
Why?
|
| Reward | 1 | 2016 | 46 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2014 | 554 | 0.120 |
Why?
|
| Learning | 1 | 2016 | 99 | 0.120 |
Why?
|
| Brain | 3 | 2013 | 753 | 0.120 |
Why?
|
| Female | 4 | 2025 | 15472 | 0.120 |
Why?
|
| Extinction, Psychological | 1 | 2014 | 4 | 0.110 |
Why?
|
| Cognition | 1 | 2018 | 327 | 0.110 |
Why?
|
| Genotype | 2 | 2013 | 461 | 0.110 |
Why?
|
| Medulla Oblongata | 1 | 2014 | 12 | 0.110 |
Why?
|
| Receptors, Glutamate | 1 | 2013 | 3 | 0.100 |
Why?
|
| Ganglionic Blockers | 1 | 2013 | 3 | 0.100 |
Why?
|
| Rats, Inbred Strains | 1 | 2013 | 63 | 0.100 |
Why?
|
| Species Specificity | 1 | 2013 | 193 | 0.100 |
Why?
|
| Glucose | 1 | 2014 | 208 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2014 | 206 | 0.100 |
Why?
|
| Action Potentials | 1 | 2013 | 196 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2013 | 273 | 0.090 |
Why?
|
| Bulimia | 1 | 2011 | 2 | 0.090 |
Why?
|
| Corticosterone | 1 | 2011 | 34 | 0.090 |
Why?
|
| Phenotype | 1 | 2013 | 682 | 0.090 |
Why?
|
| Taste | 3 | 2005 | 26 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 633 | 0.080 |
Why?
|
| Injections, Intraventricular | 1 | 2009 | 7 | 0.080 |
Why?
|
| Microinjections | 1 | 2009 | 14 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 1600 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2011 | 229 | 0.070 |
Why?
|
| Postural Balance | 2 | 2005 | 41 | 0.070 |
Why?
|
| Reflex | 2 | 2005 | 74 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 458 | 0.070 |
Why?
|
| Metabolic Clearance Rate | 1 | 2005 | 18 | 0.060 |
Why?
|
| Body Temperature | 1 | 2005 | 30 | 0.060 |
Why?
|
| Motor Skills | 1 | 2005 | 34 | 0.060 |
Why?
|
| tau Proteins | 1 | 2024 | 29 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2005 | 207 | 0.050 |
Why?
|
| Appetitive Behavior | 2 | 2001 | 2 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 60 | 0.050 |
Why?
|
| Receptors, Opioid, delta | 1 | 2002 | 9 | 0.050 |
Why?
|
| Receptors, Opioid, mu | 1 | 2002 | 22 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 46 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 224 | 0.050 |
Why?
|
| Receptors, Drug | 1 | 2001 | 1 | 0.040 |
Why?
|
| Eating | 1 | 2001 | 70 | 0.040 |
Why?
|
| Humans | 2 | 2024 | 28585 | 0.040 |
Why?
|
| Retinal Dehydrogenase | 1 | 2020 | 10 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2020 | 92 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2001 | 70 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 157 | 0.040 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 1 | 0.040 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2019 | 1 | 0.040 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2019 | 1 | 0.040 |
Why?
|
| Pars Compacta | 1 | 2019 | 2 | 0.040 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2019 | 31 | 0.040 |
Why?
|
| Dendrites | 1 | 2019 | 25 | 0.040 |
Why?
|
| Cocaine-Related Disorders | 1 | 2019 | 17 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2019 | 51 | 0.040 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2019 | 17 | 0.040 |
Why?
|
| Parkinsonian Disorders | 1 | 2018 | 2 | 0.040 |
Why?
|
| Reversal Learning | 1 | 2018 | 8 | 0.040 |
Why?
|
| Spatial Memory | 1 | 2018 | 15 | 0.040 |
Why?
|
| Saccharin | 2 | 2011 | 2 | 0.040 |
Why?
|
| Self Medication | 1 | 2018 | 4 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2018 | 68 | 0.040 |
Why?
|
| Quinine | 2 | 2011 | 23 | 0.040 |
Why?
|
| Alcoholism | 1 | 2019 | 119 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2020 | 1009 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 236 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 130 | 0.030 |
Why?
|
| Motivation | 1 | 1998 | 213 | 0.030 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2013 | 1 | 0.030 |
Why?
|
| Iontophoresis | 1 | 2013 | 3 | 0.030 |
Why?
|
| Dopamine Agents | 1 | 2013 | 2 | 0.030 |
Why?
|
| Biophysics | 1 | 2013 | 14 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 2013 | 52 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2014 | 202 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 242 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2013 | 255 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 391 | 0.020 |
Why?
|
| Time | 1 | 2011 | 16 | 0.020 |
Why?
|
| Swimming | 1 | 2011 | 32 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2004 | 15 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2002 | 8 | 0.010 |
Why?
|
| Autoradiography | 1 | 2002 | 29 | 0.010 |
Why?
|
| Receptors, Cannabinoid | 1 | 2001 | 1 | 0.010 |
Why?
|